25 results
DEFA14A
EQ
Equillium Inc
11 Apr 24
Additional proxy soliciting materials
4:07pm
or e-mail copy of the proxy material, you must request one. There is no charge to you for requesting a copy. In order to receive a paper package
8-K
EX-99.1
EQ
Equillium Inc
8 Nov 23
Equillium Announces Data from Phase 1b EQUALISE Study Presented at the 2023 Annual Meeting of the American Society of Nephrology
4:05pm
the study is largely complete, we plan to deliver the full data package to Ono Pharmaceutical under the terms of our strategic partnership in early … to, statements regarding Equillium’s plan to deliver full data package from its EQUALISE study to Ono Pharmaceuticals in early 2024, the potential benefits
8-K
EX-99.1
EQ
Equillium Inc
16 Oct 23
Regulation FD Disclosure
8:05am
Package Insert
Dr. Arash Mostaghimi Alopecia Areata Fireside Chat Arash Mostaghimi, M.D., M.P.A., M.P.H. Associate Professor of Dermatology Harvard
DEFA14A
wh6fz0uo3icy4261h
13 Apr 23
Additional proxy soliciting materials
4:03pm
PRE 14A
az86bsnygf7uey9
31 Mar 23
Preliminary proxy
4:02pm
DEFA14A
tfgpqg0d
13 Apr 22
Additional proxy soliciting materials
4:09pm
8-K
EX-2.1
8oayebggisyt2ne
16 Feb 22
Equillium Acquires Bioniz Therapeutics
7:01am
DEFA14A
lxck9 r8ca3v
9 Apr 21
Additional proxy soliciting materials
4:13pm
424B5
2w9l83gg
14 Aug 20
Prospectus supplement for primary offering
4:45pm
424B5
xo6bfyt ci
13 Aug 20
Prospectus supplement for primary offering
4:04pm
8-K
EX-99.1
babqn33 wlaw1vbb
12 Aug 20
Equillium Reports Second Quarter 2020 Financial Results and Recent Highlights
8:40am
8-K
d11npf a1
10 Aug 20
Equillium Announces Positive Interim Data with Itolizumab in Acute GVHD Study
5:21pm